Invention Grant
- Patent Title: Recombinant adenoviruses and use thereof
-
Application No.: US16159336Application Date: 2018-10-12
-
Publication No.: US10781427B2Publication Date: 2020-09-22
- Inventor: Dan H. Barouch , Herbert Virgin, IV , Peter Abbink
- Applicant: Beth Israel Deaconess Medical Center, Inc. , Washington University
- Applicant Address: US MA Boston US MO St. Louis
- Assignee: Beth Israel Deaconess Medical Center, Inc.,Washington University
- Current Assignee: Beth Israel Deaconess Medical Center, Inc.,Washington University
- Current Assignee Address: US MA Boston US MO St. Louis
- Agency: Clark & Elbing LLP
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C12N7/00 ; C12N15/74 ; A61K39/23 ; A61K39/12 ; A61K39/00
Abstract:
The present invention relates to recombinant adenoviruses and vectors thereof. In particular, the adenoviruses are novel simian adenoviruses having a low seroprevalence and high immunogenicity relative to other adenoviruses and vectors thereof. The invention also provides methods for production of the adenoviruses and for the treatment of diseases by administering the adenoviral vector(s) to a subject (e.g., a human).
Public/Granted literature
- US20190136205A1 RECOMBINANT ADENOVIRUSES AND USE THEREOF Public/Granted day:2019-05-09
Information query
IPC分类:
